RATED A+ 2025/2026 UPDATED NEW!!
Women aged 65 and older AND younger women with fracture risk of 9.3% or higher - screen for
osteoporosis with DEXA
Ibuprofen / naproxen for primary dysmenorrhea, if side effect or not controlled, - OCP
Reduce risk of pressure ulcers in at risk-pa-ents - use advanced sta-c ma/resses of overlays
life expectancy of at least --- years is expected to benefit from screening mammography - 10
years
Frequent episodes of binge ea-ng >1/week followed by innapropriate compensatory behaviors
(vomi-ng, laxa-ves,enema etc) due to fear of gaining weight - Bulimia nervosa
anorexia BMI - generally underweight, or less than 18.5
o--s media with effusion management - observe, usually resolves in 12 weeks
o--s externa treatment - combined an-bio-c and glucocor-coid ototopical medica-on, ee.g
neomycin +polymyxin b +hydrocor-sone
topical lidocaine is effec-ve in treatment of herpe-c neuralgia - topical lidocaine
describe uvei-s - unilateral eye pain, photophobia, ciliary flush (Circumferen-al redness along
the border of the sclera and cornea), there may be miosis
, Indica-ons for bariatric surgery - BMI 40 or higher without comorbidi-es, BMI 35 with
comorbi-es
Orlistat - Weight loss medica-on, loose stool common side effect. Lose about 3.5kg over 1 year
Lorcaserin - Weight loss medica-on, avoid in pts taking SSRIs sue to eleva-on in serotonin
Phentermine-topiramate - Weight loss medica-on, avoid in glaucoma
acromioclavicular join degenera-on presenta-on - pain on superior aspect of shoulder,
tenderness on palpa-on of A-C joint, pain with shoulder adduc-on and abduc-on >120 degrees
Supraspinatus tear test - Posi-ve drop arm test
supraspinatus tendini-s - pain on shoulder abduc-on or painful arc
Lung cancer screening - ANNUAL LOW-DOSE CT for age 55-80 years with 30-pack year smoking
history, including those who quit within 15 years
AAA Screening - One -me abdominal US for men 65-75 who have smoked at least 100
cigarre/es
standard outcome measure for cohort study - rela-ve risk
Treatment op-ons for bipolar depression - Seroquel monotherapy, combina-on olanzapine-
fluoxe-ne
, hormonal estrogen is contraindicated in women with migraines+aura due to risk of - stroke
PAP smear screening - women 21-65 , every 3 years. In women 30 - 65, every 5 years if
combined with HPV tes-ng
Indica-ons for high intensity sta-n - Age 40 - 75 with diabetes and an LDL of 70 - 189,and 10
years >7.5% ASCVD risk
men with low or low-normal testosterone level should have a repeat confirmatory morning
testosterone prior to begining testosterone treatment -
severe vasomotor symptoms in postmenopausal women are best treated with - systemic
hormonal therapy;- oral estradiol-progres-n combo
test to be performed in all pa-ents with syncope - EKG
Panic disorder treatment - SSRI (sertraline), SNRI, TCAs, MAOi
Trichomoniasis treatment - single dose of metronidazole 2g, and treat partner
Treatment of vasomotor symptoms in postmenopausal women without a uterus - Transdermal
or oral Estradiol only (no need for proges-n as they have no uterus)
Sta-ns, ACE-i/ARB are teratogenic - discon-nue in pregnant women
Indica-ons for pharmacologic weight loss treatment - BMI greater than 30, or BMI greater than
27 with obesity associated complica-ons